Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care. / Nielsen, Ole Haagen; Pardi, Darrell S.

I: Drugs and Aging, Bind 41, 2024, s. 113-123.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Nielsen, OH & Pardi, DS 2024, 'Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care', Drugs and Aging, bind 41, s. 113-123. https://doi.org/10.1007/s40266-023-01094-6

APA

Nielsen, O. H., & Pardi, D. S. (2024). Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care. Drugs and Aging, 41, 113-123. https://doi.org/10.1007/s40266-023-01094-6

Vancouver

Nielsen OH, Pardi DS. Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care. Drugs and Aging. 2024;41:113-123. https://doi.org/10.1007/s40266-023-01094-6

Author

Nielsen, Ole Haagen ; Pardi, Darrell S. / Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care. I: Drugs and Aging. 2024 ; Bind 41. s. 113-123.

Bibtex

@article{e94d3deaf2c6439094942b52465b62df,
title = "Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care",
abstract = "Microscopic colitis, a diagnosis under the umbrella term of inflammatory bowel disease, is a prevalent cause of watery diarrhea, often with symptoms of urgency and bloating, typically observed in older adults aged ≥ 60 years. Its incidence has been reported to exceed those of ulcerative colitis and Crohn{\textquoteright}s disease in some geographical areas. Although nonpathognomonic endoscopic abnormalities, including changes of the vascular mucosal pattern; mucosal erythema; edema; nodularity; or mucosal defects, e.g., “cat scratches” have been reported, a colonoscopy is typically macroscopically normal. As reliable biomarkers are unavailable, colonoscopy using random biopsies from various parts of the colon is compulsory. Based on the histological examination under a microscope, the disease is divided into collagenous (with a thickened subepithelial collagenous band) and lymphocytic (with intraepithelial lymphocytosis) colitis, although incomplete forms exist. In routine clinical settings, the disease has a high risk of being misdiagnosed as irritable bowel syndrome or even overlooked. Therefore, healthcare providers should be familiar with clinical features and rational management strategies. A 6–8-week oral budesonide treatment course (9 mg/day) is considered the first-line therapy, but patients often experience relapse when discontinued, or might become intolerant, dependent, or even fail to respond. Consequently, other therapeutic options (e.g., bismuth subsalicylate, biologics, loperamide, bile acid sequestrants, and thiopurines) recommended by available guidelines may be prescribed. Herein, clinically meaningful data is provided based on the latest evidence that may aid in reaching a diagnosis and establishing rational therapy in geriatric care to control symptoms and enhance the quality of life for those affected.",
author = "Nielsen, {Ole Haagen} and Pardi, {Darrell S.}",
note = "Publisher Copyright: {\textcopyright} 2024, The Author(s).",
year = "2024",
doi = "10.1007/s40266-023-01094-6",
language = "English",
volume = "41",
pages = "113--123",
journal = "Drugs & Aging",
issn = "1170-229X",
publisher = "Adis International Ltd",

}

RIS

TY - JOUR

T1 - Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care

AU - Nielsen, Ole Haagen

AU - Pardi, Darrell S.

N1 - Publisher Copyright: © 2024, The Author(s).

PY - 2024

Y1 - 2024

N2 - Microscopic colitis, a diagnosis under the umbrella term of inflammatory bowel disease, is a prevalent cause of watery diarrhea, often with symptoms of urgency and bloating, typically observed in older adults aged ≥ 60 years. Its incidence has been reported to exceed those of ulcerative colitis and Crohn’s disease in some geographical areas. Although nonpathognomonic endoscopic abnormalities, including changes of the vascular mucosal pattern; mucosal erythema; edema; nodularity; or mucosal defects, e.g., “cat scratches” have been reported, a colonoscopy is typically macroscopically normal. As reliable biomarkers are unavailable, colonoscopy using random biopsies from various parts of the colon is compulsory. Based on the histological examination under a microscope, the disease is divided into collagenous (with a thickened subepithelial collagenous band) and lymphocytic (with intraepithelial lymphocytosis) colitis, although incomplete forms exist. In routine clinical settings, the disease has a high risk of being misdiagnosed as irritable bowel syndrome or even overlooked. Therefore, healthcare providers should be familiar with clinical features and rational management strategies. A 6–8-week oral budesonide treatment course (9 mg/day) is considered the first-line therapy, but patients often experience relapse when discontinued, or might become intolerant, dependent, or even fail to respond. Consequently, other therapeutic options (e.g., bismuth subsalicylate, biologics, loperamide, bile acid sequestrants, and thiopurines) recommended by available guidelines may be prescribed. Herein, clinically meaningful data is provided based on the latest evidence that may aid in reaching a diagnosis and establishing rational therapy in geriatric care to control symptoms and enhance the quality of life for those affected.

AB - Microscopic colitis, a diagnosis under the umbrella term of inflammatory bowel disease, is a prevalent cause of watery diarrhea, often with symptoms of urgency and bloating, typically observed in older adults aged ≥ 60 years. Its incidence has been reported to exceed those of ulcerative colitis and Crohn’s disease in some geographical areas. Although nonpathognomonic endoscopic abnormalities, including changes of the vascular mucosal pattern; mucosal erythema; edema; nodularity; or mucosal defects, e.g., “cat scratches” have been reported, a colonoscopy is typically macroscopically normal. As reliable biomarkers are unavailable, colonoscopy using random biopsies from various parts of the colon is compulsory. Based on the histological examination under a microscope, the disease is divided into collagenous (with a thickened subepithelial collagenous band) and lymphocytic (with intraepithelial lymphocytosis) colitis, although incomplete forms exist. In routine clinical settings, the disease has a high risk of being misdiagnosed as irritable bowel syndrome or even overlooked. Therefore, healthcare providers should be familiar with clinical features and rational management strategies. A 6–8-week oral budesonide treatment course (9 mg/day) is considered the first-line therapy, but patients often experience relapse when discontinued, or might become intolerant, dependent, or even fail to respond. Consequently, other therapeutic options (e.g., bismuth subsalicylate, biologics, loperamide, bile acid sequestrants, and thiopurines) recommended by available guidelines may be prescribed. Herein, clinically meaningful data is provided based on the latest evidence that may aid in reaching a diagnosis and establishing rational therapy in geriatric care to control symptoms and enhance the quality of life for those affected.

U2 - 10.1007/s40266-023-01094-6

DO - 10.1007/s40266-023-01094-6

M3 - Journal article

C2 - 38231321

AN - SCOPUS:85182434567

VL - 41

SP - 113

EP - 123

JO - Drugs & Aging

JF - Drugs & Aging

SN - 1170-229X

ER -

ID: 380696966